Scrip M&A Podcast: Assessing The Biopharma Deals Environment At Midyear

 
• By Joseph Haas, Kevin Grogan, and Mandy Jackson
Midyear M&A podcast
Scrip editors look ahead to biopharma dealmaking in the second half of 2024 • Source: Shutterstock

More from Strategy

More from Business